Literature DB >> 14752618

Myocardial taurine, development and vulnerability to ischemia.

P Modi1, M-S Suleiman.   

Abstract

Depleting intracellular taurine in heart cells improves their resistance to ischemia and reperfusion injury. The aim of this work was to see whether physiologically low levels of endogenous taurine also reflect a reduced vulnerability of the myocardium to cardiac insults. The myocardial concentration of taurine was measured during different stages of development and compared with vulnerability to ischemia and reperfusion injury in the rat and in pediatric patients undergoing cardiac surgery.Rat hearts with relatively lower levels of taurine were significantly more resistant to an ischemic inult and there was a strong negative correlation between taurine content and recovery. Children's hearts had significantly lower taurine levels compared to infants' hearts which was consistent with their known increased resistance to an ischemic cardioplegic insult (Imura et al., 2001). This work shows that the changes in the concentration of myocardial taurine during development correlate with vulnerability to ischemia where low myocardial taurine is associated with improved recovery upon reperfusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14752618     DOI: 10.1007/s00726-003-0031-y

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

1.  Changes in the mitochondrial function and in the efficiency of energy transfer pathways during cardiomyocyte aging.

Authors:  Kersti Tepp; Marju Puurand; Natalja Timohhina; Jasper Adamson; Aleksandr Klepinin; Laura Truu; Igor Shevchuk; Vladimir Chekulayev; Tuuli Kaambre
Journal:  Mol Cell Biochem       Date:  2017-03-14       Impact factor: 3.396

Review 2.  Physiological roles of taurine in heart and muscle.

Authors:  Stephen W Schaffer; Chian Ju Jong; K C Ramila; Junichi Azuma
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

3.  Normoxic and hyperoxic cardiopulmonary bypass in congenital heart disease.

Authors:  Amir Mokhtari; Martin Lewis
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

4.  Cardioprotection of Immature Heart by Simultaneous Activation of PKA and Epac: A Role for the Mitochondrial Permeability Transition Pore.

Authors:  Martin John Lewis; Igor Khaliulin; Katie Hall; M Saadeh Suleiman
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 6.208

5.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

6.  Taurine suppresses the spread of cell death in electrically coupled RPE cells.

Authors:  Chandani Udawatte; Haohua Qian; Nancy J Mangini; Brian G Kennedy; Harris Ripps
Journal:  Mol Vis       Date:  2008-10-29       Impact factor: 2.367

7.  Consecutive Isoproterenol and Adenosine Treatment Confers Marked Protection against Reperfusion Injury in Adult but Not in Immature Heart: A Role for Glycogen.

Authors:  Martin Lewis; Adrian Szobi; Dirki Balaska; Igor Khaliulin; Adriana Adameova; Elinor Griffiths; Clive H Orchard; M-Saadeh Suleiman
Journal:  Int J Mol Sci       Date:  2018-02-07       Impact factor: 5.923

Review 8.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.